Why Patients Switch: Wegovy vs Mounjaro Comparison
Is Wegovy or Mounjaro Better for Switching Patients?
When considering whether Wegovy or Mounjaro is better for your needs, understanding the key differences helps inform your decision. Wegovy contains semaglutide, a GLP-1 receptor agonist that has been extensively studied in the STEP trial programme, whilst Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist. Many patients switch between these prescription-only medicines due to tolerability differences, with some finding one causes fewer gastrointestinal side effects than the other. The decision of whether Wegovy or Mounjaro is better often depends on individual response patterns and practical considerations like storage requirements.
EverydayMeds stocks both medications, allowing seamless transitions under prescriber supervision without changing pharmacies. Our clinical team understands that determining whether Wegovy or Mounjaro is better requires personalised assessment of your medical history, current response, and treatment goals. Patients frequently switch when seeking improved tolerability, better weight management outcomes, or more convenient dosing schedules. The question of is Wegovy or Mounjaro better ultimately depends on how each medication fits your lifestyle and responds to your individual physiology.
Wegovy vs Mounjaro Pricing: Switch and Save Analysis
Cost considerations play a crucial role when deciding is Wegovy or Mounjaro better for your budget. Wegovy pricing at EverydayMeds starts with 0.25mg pens at £79.99, progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, to maintenance 2.4mg pens at £209.99. New customers can apply discount code FIRST40 at checkout to reach these competitive prices, whilst returning customers use code DOSE25. Our Getting Started bundles provide additional value, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, helping patients beginning their dose escalation journey.
When comparing costs to determine is Wegovy or Mounjaro better financially, consider the complete treatment pathway rather than individual pen prices. Wegovy's structured dose escalation over 16 weeks means predictable costs, with our Step-Up bundles like the Intro Trio (0.25mg, 0.5mg & 1mg) available for £299.99. Maintenance therapy typically requires 2.4mg monthly, with our Consistency 2.4mg bundle providing two pens for £419.99. The question of whether Wegovy or Mounjaro is better from a cost perspective depends on your insurance coverage, dosing requirements, and available pharmacy discounts at the time of switching.
Clinical Evidence: Is Wegovy or Mounjaro Better Supported?
The clinical evidence base helps answer whether Wegovy or Mounjaro is better for weight management outcomes. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 study (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different patient populations, with STEP 2 showing clinically studied weight loss in patients with type 2 diabetes.
When evaluating is Wegovy or Mounjaro better from an evidence perspective, both medications have robust clinical trial support, though direct head-to-head comparisons are limited. The SELECT cardiovascular outcomes trial showed Wegovy may reduce major cardiovascular events by 20% in eligible patients. However, determining whether Wegovy or Mounjaro is better clinically requires individual assessment, as trial populations and endpoints differ between studies.
How Wegovy Works: Understanding the Mechanism
Understanding how Wegovy functions helps answer whether Wegovy or Mounjaro is better for your specific needs. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, which is released after eating. This prescription-only medicine works by binding to GLP-1 receptors in the brain's appetite control centres, reducing hunger signals and increasing feelings of fullness. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Wegovy also appears to reduce food cravings and the reward value of high-calorie foods through its action on neural pathways. When used alongside a reduced-calorie diet and increased physical activity, these mechanisms work together to support significant weight management outcomes.
EverydayMeds Ordering Process for Switching Medications
Switching medications to determine whether Wegovy or Mounjaro is better becomes straightforward with EverydayMeds' streamlined process. Our 3-minute online clinical assessment captures your medical history, current medications, and switching rationale, allowing prescribers to make informed decisions about dose equivalents and timing. Prescriber review typically takes 3 working days, though express 24-hour review is available for urgent switches. Once approved, your prescription-only medicine is dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication stability. Our GPhC-registered pharmacy (GPhC #9012878) ensures full regulatory compliance throughout the switching process. The entire transition from assessment to delivery typically takes 4-5 working days, minimising any gap in your weight management therapy.
Storage Advantages: Wegovy vs Mounjaro Practical Considerations
Storage requirements often influence whether Wegovy or Mounjaro is better for your lifestyle needs. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but offer a significant advantage once removed from cold storage. Unlike Mounjaro's 21-day room temperature limit, Wegovy pens can be kept at room temperature (below 30°C) for up to 6 weeks, making them ideal for extended travel or work situations. Each Wegovy pen uses Novo Nordisk's FlexTouch injection system, pre-filled and ready to use with built-in dose counters. The dose escalation schedule progresses every 4 weeks: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, then 2.4mg for maintenance. This extended room temperature stability often tips the scales when patients ask whether Wegovy or Mounjaro is better for their practical circumstances.
Switching Strategies: Making the Transition Successfully
Successfully switching requires understanding equivalent doses when determining is Wegovy or Mounjaro better for continued treatment. Patients typically switch due to side effect profiles, with some finding gastrointestinal effects more manageable with one medication versus the other. Our prescribers provide guidance on approximate dose conversions, though individual titration may be necessary based on tolerability and response. The transition period usually involves a brief washout or direct switch depending on your current dose and medical history.
Timing your switch strategically can help determine whether Wegovy or Mounjaro is better suited to your routine. Some patients prefer switching at lower doses to minimise adjustment effects, whilst others wait until experiencing specific issues with their current medication. EverydayMeds maintains stock of both medications, ensuring supply continuity regardless of which direction your switch takes you. The question of is Wegovy or Mounjaro better often becomes clearer after experiencing both under medical supervision.
Complete Your Switch with EverydayMeds Expert Support
Making the final decision about whether Wegovy or Mounjaro is better becomes easier with EverydayMeds' comprehensive support throughout your switching journey. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 for ongoing savings on both medications. Our clinical team provides personalised guidance on dose equivalents, timing strategies, and what to expect during the transition period. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and explore both medication options with competitive pricing and next-day delivery. As a GPhC-registered pharmacy (#9012878), we ensure your switch between these prescription-only medicines meets all regulatory requirements whilst supporting your long-term weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
